SlideShare a Scribd company logo
1.0        Alcohol
      Brian J. Piper, Ph.D.
1.2
                         Goals
      •   Chemistry
      •   Pharmacokinetics
      •   Pharmacodynamics
      •   Physiological effects
      •   Public health consequences
      •   Teratology
      •   Epidemiology
1.2
                 Chemistry
• Ethanol: CH3CH2OH
1.3   Getting in:
      •   1. Mouth
      •   2. Stomach
      •   3. Small intestine
      •   4. Heart
      •   5. Brain
      •   6. Liver
3.7                       Getting out
    • Alcohol dehydrogenase (AlcDH):
    • Aldehyde dehydrogenase (AldDH)

                        AlcDH                          AldDH
    • Ethanol   -------->            Acetaldehyde ------> Acetic Acid
      CH3-CH2-OH                    CH3-CH=O             CH3-C-OH
                                                             ||
                                                               O
    AlcDH: lower levels in stomach of women
    AldDH: half of Asians have a dysfunctional version; this
      results in flushing and nausea, Antabuse inhibits

See also: http://endeavor.med.nyu.edu/~strone01/doctor.html
2.7
                 Sex Differences
      • Lower level of AlcDH in stomach of
        females
      • Fat content
      • Sex hormones
      • Tolerance
1.8
            Pharmacodynamics
 • Primary
      – decrease glutamate
      – increase GABA
 • Secondary
      – increase Dopamine
3.1




      Doyon, W.M.,et al. (2005). J Neurochem, 93, 1469-1481.
Physiological                  Blood Alcohol
                                                Concentration   Symptom
      5.1
                   Effects                      Low (O.01%*)    relaxation
            • Dose dependent:                                   Decreased
                                                                alertness
                     – low dose-stimulant
                                                                Loss of coordination/
                     – high dose-depressant                     reaction time
                                                                Difficulty standing/
                                                                walking

                                                                Slurred speech

                                                                Unable to walk
Table From Inaba, D.S. (2007).
                                                                unaided
                                 *Mass/Volume                   Difficulty rousing
                                 mg/dL
                                                                Coma
                                                High (0.50)     Death
2004 Fatalities in Motor Vehicle Traffic Crashes
             by Driver BAC – Massachusetts
2.9




                                                 .01-.07
                                                   BAC                                      .08-.09 BAC 11.0%
                                                  4.7%

                                                                                             .10-.14 BAC
                                                                                                26.4%
                Zero BAC                            .08+ BAC
                 61.1%                                34.5%
                                                                                              .15+ BAC
                                                                                                62.6%



                                                                       The average BAC among drunk drivers
                                                                      involved in fatal crashes was 0.17 (2004).

      Source: National Highway Traffic Safety Administration, U.S. Department of Transportation, 2005. Fatalities in motor
      vehicle traffic crashes by the highest driver BAC in the crash, 2004 Fatal Analysis Reporting System (FARS).
Preventable
                                                                                              deaths.



   Alcohol related fatality = one member of accident (driver, nonoccupant) has detectable
   Alcohol (0.01 g/dl +) ,

   There were 43,295 traffic fatalities (39% alcohol related).




http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdftp://
.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdf
Chronic EtOH & Neurophsyiology
3.3




Find X among other letters,
“Oddball” task




      Chorlian, D.B. (1995). Alcohol Health & Research World 19(4):315–320.
Chronic EtOH & Neuroanatomy
2.6




 Rosenbloom, M., et al. (2003). Alcohol Research & Health 27(2):146–152.
1.5

                                   Teratology: High dose




Warren, Kenneth (2011). Perspectives on Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders. Available at: http://videocast.nih.gov/launch.asp?16613
Low-Dose?
    •       Women in Capetown, South Africa were interviewed after giving birth and their
            offspring were grouped as:
              – Unexposed Control (N=29): no EtOH
              – Fetal Alcohol Syndrome (N=12): 4.2 drinks/day
              – Partial FAS (N=18): 2.8 drinks/day
                                         http://www.nlm.nih.gov/medlineplus/ency/images/ency/fu
              – Heavy Exposed (N=34): 1.6 drinks/day
              – Microencephalic (N=4): ?
    •       Children were tested at age 5
             for classical conditioning:




Jacobson, S.W., et al. (2008). Alcohol: Clin Exp Res 37, 2, 365-372.
Jacobson, S.W., et al. (2008).
Alcohol: Clin Exp Res 37, 2, 365-372.
Monitoring the Future
• National survey, conducted annually by NIDA of
  secondary school (8th, 10th, or 12th), college
  students, and adults (<45 yrs)
• Missing data (drop-outs = 15%, not attending) =
  under-estimation
• Concern about labels (inadvertent marketing)
• Self-report
  – Knowledge (e.g. steroids, diet pills, club drugs)
  – Memory (e.g. How many drinks?)
  – Taboo

     http://www.monitoringthefuture.org/
Demographics
• Compares use by:
  – Year (1975 – present)
  – Sex
  – Ethnicity
  – Parental education
                            ?
  – Region
  – College plans
Frequency of Alcohol Use
• Monitoring
  the Future
• Nationally
  representative
• 15,000+
Frequency of Alcohol Use
• Monitoring
  the Future
• Nationally
  representative
• 15,000+
Epidemiology




 MtF: http://www.monitoringthefuture.org/pubs/occpapers/occ63.pdf
http://www.monitoringthefuture.org/data/06data/fig06_14.pdf
Drug Abuse Warning Network
• Nationwide reports of ER/ED visits
• 242 hospitals nationwide
• Drug/alcohol is “implicated”
  – Overdose
  – Suicide
  – Accident
Drug Abuse Warning Network
3.5          Alcoholics Anonymous
      • Founded by Bill Wilson & Bob Smith in 1935
      • Medical-Spiritual Approach based on:
        – Alcoholism is a progressive disease.
        – Alcoholics must give themselves to a higher power.
        – Total abstinence
      • Effectiveness ?
Public Health

                  Premature       Safety in        Brain    Interpersonal   Traffic     cirrhosis   Heart    Cost
                  Deaths          overdose         Damage   Violence        Accidents               Damage   to society
                  (UK)                                                                                       (Billion
                                                                            Per year
                                                                                                             Pounds)
                                                            10,000 +/year
ethanol           22,000                                                    1500
                                  10 x Yes                                              ++          ++       18.5
                                  Pleasure
                                  dose




ecstasy                                                                                                      0.01
                  10              15 x ?                    0               0           0           0


Nutt, D.J. (2006) J. Psychopharmacology, 20, 315-317.
Summary

    • Pharmacokinetics: enzymes
    • Pharmacodynamics: neurotransmitters
    • Teratology: consequences
              – Randall: http://videocast.nih.gov/launch.asp?10420

    • Epidemiology: Who uses? What are risk
      factors?


Total Length = 57.4 minutes

More Related Content

Viewers also liked

Introductory Psychology: Social Psychology
Introductory Psychology: Social PsychologyIntroductory Psychology: Social Psychology
Introductory Psychology: Social Psychology
Brian Piper
 
Neuropharmacology: Introduction
Neuropharmacology: IntroductionNeuropharmacology: Introduction
Neuropharmacology: Introduction
Brian Piper
 
Research Methods: Ethics II (Animal Research)
Research Methods: Ethics II (Animal Research)Research Methods: Ethics II (Animal Research)
Research Methods: Ethics II (Animal Research)
Brian Piper
 
Neuropharmacology: Anxiety Disorders
Neuropharmacology: Anxiety DisordersNeuropharmacology: Anxiety Disorders
Neuropharmacology: Anxiety Disorders
Brian Piper
 
Neuropharmacology: GABA & Glutamate
Neuropharmacology: GABA & GlutamateNeuropharmacology: GABA & Glutamate
Neuropharmacology: GABA & Glutamate
Brian Piper
 
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Brian Piper
 
Research Methods: Survey Research
Research Methods: Survey ResearchResearch Methods: Survey Research
Research Methods: Survey Research
Brian Piper
 
Observation In Research
Observation In ResearchObservation In Research
Observation In Research
Marites Hugo
 

Viewers also liked (8)

Introductory Psychology: Social Psychology
Introductory Psychology: Social PsychologyIntroductory Psychology: Social Psychology
Introductory Psychology: Social Psychology
 
Neuropharmacology: Introduction
Neuropharmacology: IntroductionNeuropharmacology: Introduction
Neuropharmacology: Introduction
 
Research Methods: Ethics II (Animal Research)
Research Methods: Ethics II (Animal Research)Research Methods: Ethics II (Animal Research)
Research Methods: Ethics II (Animal Research)
 
Neuropharmacology: Anxiety Disorders
Neuropharmacology: Anxiety DisordersNeuropharmacology: Anxiety Disorders
Neuropharmacology: Anxiety Disorders
 
Neuropharmacology: GABA & Glutamate
Neuropharmacology: GABA & GlutamateNeuropharmacology: GABA & Glutamate
Neuropharmacology: GABA & Glutamate
 
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
 
Research Methods: Survey Research
Research Methods: Survey ResearchResearch Methods: Survey Research
Research Methods: Survey Research
 
Observation In Research
Observation In ResearchObservation In Research
Observation In Research
 

Similar to Neuropharmacology: Alcohol

Multiple Pathways to Addiction - Robert Pihl
Multiple Pathways to Addiction - Robert PihlMultiple Pathways to Addiction - Robert Pihl
Multiple Pathways to Addiction - Robert Pihl
Centre for Health Evaluation and Outcome Sciences
 
Alcohol A delightful poison pub
Alcohol A delightful poison pubAlcohol A delightful poison pub
Alcohol A delightful poison pubmherie
 
Danielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study PpDanielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study PpDanielleDDI
 
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
Kelli Buckreus
 
Lifestyle and chronic diseases - Dr.Ravi Andrews
Lifestyle and chronic diseases  - Dr.Ravi Andrews Lifestyle and chronic diseases  - Dr.Ravi Andrews
Lifestyle and chronic diseases - Dr.Ravi Andrews
Apollo Hospitals
 
The Effects of Drugs on Driving
The Effects of Drugs on DrivingThe Effects of Drugs on Driving
The Effects of Drugs on Driving
Texas A&M Transportation Institute
 
Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal
Andri Andri
 
Cowan Reg Tox Pharm 78 24 2016
Cowan Reg Tox Pharm 78 24 2016Cowan Reg Tox Pharm 78 24 2016
Cowan Reg Tox Pharm 78 24 2016Lisa Stabryla
 
The global and regional burden of major risk factors, and lessons for NCD pre...
The global and regional burden of major risk factors, and lessons for NCD pre...The global and regional burden of major risk factors, and lessons for NCD pre...
The global and regional burden of major risk factors, and lessons for NCD pre...وزارة الصحة السعودية
 
Research Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant MetabolismResearch Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant Metabolism
keijello
 
DM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACCDM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACC
David Garby
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
Golden Eye
 
Soul city phuza wise campaign meeting c parry
Soul city phuza wise campaign meeting  c parrySoul city phuza wise campaign meeting  c parry
Soul city phuza wise campaign meeting c parry
NCAS1
 
Neuropharmacology: Stimulants
Neuropharmacology: StimulantsNeuropharmacology: Stimulants
Neuropharmacology: Stimulants
Brian Piper
 
Medications-for-treatment-of-alcohol-dependence.ppt
Medications-for-treatment-of-alcohol-dependence.pptMedications-for-treatment-of-alcohol-dependence.ppt
Medications-for-treatment-of-alcohol-dependence.ppt
kapilsojitra63
 
Hanson 10e Pp Ts Ch07
Hanson 10e Pp Ts Ch07Hanson 10e Pp Ts Ch07
Hanson 10e Pp Ts Ch07Bryan
 

Similar to Neuropharmacology: Alcohol (20)

i29.full
i29.fulli29.full
i29.full
 
Multiple Pathways to Addiction - Robert Pihl
Multiple Pathways to Addiction - Robert PihlMultiple Pathways to Addiction - Robert Pihl
Multiple Pathways to Addiction - Robert Pihl
 
Alcoholism
AlcoholismAlcoholism
Alcoholism
 
Alcohol A delightful poison pub
Alcohol A delightful poison pubAlcohol A delightful poison pub
Alcohol A delightful poison pub
 
Danielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study PpDanielle.Degroot.Case Study Pp
Danielle.Degroot.Case Study Pp
 
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
Prevalence of metabolic syndrome amongst Canadian Aboriginals attending a scr...
 
Hypertension
HypertensionHypertension
Hypertension
 
Lifestyle and chronic diseases - Dr.Ravi Andrews
Lifestyle and chronic diseases  - Dr.Ravi Andrews Lifestyle and chronic diseases  - Dr.Ravi Andrews
Lifestyle and chronic diseases - Dr.Ravi Andrews
 
Alcohoal
AlcohoalAlcohoal
Alcohoal
 
The Effects of Drugs on Driving
The Effects of Drugs on DrivingThe Effects of Drugs on Driving
The Effects of Drugs on Driving
 
Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal
 
Cowan Reg Tox Pharm 78 24 2016
Cowan Reg Tox Pharm 78 24 2016Cowan Reg Tox Pharm 78 24 2016
Cowan Reg Tox Pharm 78 24 2016
 
The global and regional burden of major risk factors, and lessons for NCD pre...
The global and regional burden of major risk factors, and lessons for NCD pre...The global and regional burden of major risk factors, and lessons for NCD pre...
The global and regional burden of major risk factors, and lessons for NCD pre...
 
Research Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant MetabolismResearch Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant Metabolism
 
DM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACCDM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACC
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
 
Soul city phuza wise campaign meeting c parry
Soul city phuza wise campaign meeting  c parrySoul city phuza wise campaign meeting  c parry
Soul city phuza wise campaign meeting c parry
 
Neuropharmacology: Stimulants
Neuropharmacology: StimulantsNeuropharmacology: Stimulants
Neuropharmacology: Stimulants
 
Medications-for-treatment-of-alcohol-dependence.ppt
Medications-for-treatment-of-alcohol-dependence.pptMedications-for-treatment-of-alcohol-dependence.ppt
Medications-for-treatment-of-alcohol-dependence.ppt
 
Hanson 10e Pp Ts Ch07
Hanson 10e Pp Ts Ch07Hanson 10e Pp Ts Ch07
Hanson 10e Pp Ts Ch07
 

More from Brian Piper

Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Brian Piper
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
Brian Piper
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Brian Piper
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
Brian Piper
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
Brian Piper
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
Brian Piper
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
Brian Piper
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
Brian Piper
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Brian Piper
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
Brian Piper
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics I
Brian Piper
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
Brian Piper
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
Brian Piper
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
Brian Piper
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
Brian Piper
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
Brian Piper
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
Brian Piper
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
Brian Piper
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Brian Piper
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
Brian Piper
 

More from Brian Piper (20)

Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics I
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
 

Recently uploaded

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 

Recently uploaded (20)

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 

Neuropharmacology: Alcohol

  • 1. 1.0 Alcohol Brian J. Piper, Ph.D.
  • 2. 1.2 Goals • Chemistry • Pharmacokinetics • Pharmacodynamics • Physiological effects • Public health consequences • Teratology • Epidemiology
  • 3. 1.2 Chemistry • Ethanol: CH3CH2OH
  • 4. 1.3 Getting in: • 1. Mouth • 2. Stomach • 3. Small intestine • 4. Heart • 5. Brain • 6. Liver
  • 5. 3.7 Getting out • Alcohol dehydrogenase (AlcDH): • Aldehyde dehydrogenase (AldDH) AlcDH AldDH • Ethanol --------> Acetaldehyde ------> Acetic Acid CH3-CH2-OH CH3-CH=O CH3-C-OH || O AlcDH: lower levels in stomach of women AldDH: half of Asians have a dysfunctional version; this results in flushing and nausea, Antabuse inhibits See also: http://endeavor.med.nyu.edu/~strone01/doctor.html
  • 6. 2.7 Sex Differences • Lower level of AlcDH in stomach of females • Fat content • Sex hormones • Tolerance
  • 7. 1.8 Pharmacodynamics • Primary – decrease glutamate – increase GABA • Secondary – increase Dopamine
  • 8. 3.1 Doyon, W.M.,et al. (2005). J Neurochem, 93, 1469-1481.
  • 9. Physiological Blood Alcohol Concentration Symptom 5.1 Effects Low (O.01%*) relaxation • Dose dependent: Decreased alertness – low dose-stimulant Loss of coordination/ – high dose-depressant reaction time Difficulty standing/ walking Slurred speech Unable to walk Table From Inaba, D.S. (2007). unaided *Mass/Volume Difficulty rousing mg/dL Coma High (0.50) Death
  • 10. 2004 Fatalities in Motor Vehicle Traffic Crashes by Driver BAC – Massachusetts 2.9 .01-.07 BAC .08-.09 BAC 11.0% 4.7% .10-.14 BAC 26.4% Zero BAC .08+ BAC 61.1% 34.5% .15+ BAC 62.6% The average BAC among drunk drivers involved in fatal crashes was 0.17 (2004). Source: National Highway Traffic Safety Administration, U.S. Department of Transportation, 2005. Fatalities in motor vehicle traffic crashes by the highest driver BAC in the crash, 2004 Fatal Analysis Reporting System (FARS).
  • 11. Preventable deaths. Alcohol related fatality = one member of accident (driver, nonoccupant) has detectable Alcohol (0.01 g/dl +) , There were 43,295 traffic fatalities (39% alcohol related). http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdftp:// .nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2005/810616.pdf
  • 12. Chronic EtOH & Neurophsyiology 3.3 Find X among other letters, “Oddball” task Chorlian, D.B. (1995). Alcohol Health & Research World 19(4):315–320.
  • 13. Chronic EtOH & Neuroanatomy 2.6 Rosenbloom, M., et al. (2003). Alcohol Research & Health 27(2):146–152.
  • 14. 1.5 Teratology: High dose Warren, Kenneth (2011). Perspectives on Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders. Available at: http://videocast.nih.gov/launch.asp?16613
  • 15. Low-Dose? • Women in Capetown, South Africa were interviewed after giving birth and their offspring were grouped as: – Unexposed Control (N=29): no EtOH – Fetal Alcohol Syndrome (N=12): 4.2 drinks/day – Partial FAS (N=18): 2.8 drinks/day http://www.nlm.nih.gov/medlineplus/ency/images/ency/fu – Heavy Exposed (N=34): 1.6 drinks/day – Microencephalic (N=4): ? • Children were tested at age 5 for classical conditioning: Jacobson, S.W., et al. (2008). Alcohol: Clin Exp Res 37, 2, 365-372.
  • 16. Jacobson, S.W., et al. (2008). Alcohol: Clin Exp Res 37, 2, 365-372.
  • 17. Monitoring the Future • National survey, conducted annually by NIDA of secondary school (8th, 10th, or 12th), college students, and adults (<45 yrs) • Missing data (drop-outs = 15%, not attending) = under-estimation • Concern about labels (inadvertent marketing) • Self-report – Knowledge (e.g. steroids, diet pills, club drugs) – Memory (e.g. How many drinks?) – Taboo http://www.monitoringthefuture.org/
  • 18. Demographics • Compares use by: – Year (1975 – present) – Sex – Ethnicity – Parental education ? – Region – College plans
  • 19.
  • 20. Frequency of Alcohol Use • Monitoring the Future • Nationally representative • 15,000+
  • 21. Frequency of Alcohol Use • Monitoring the Future • Nationally representative • 15,000+
  • 23.
  • 25. Drug Abuse Warning Network • Nationwide reports of ER/ED visits • 242 hospitals nationwide • Drug/alcohol is “implicated” – Overdose – Suicide – Accident
  • 27. 3.5 Alcoholics Anonymous • Founded by Bill Wilson & Bob Smith in 1935 • Medical-Spiritual Approach based on: – Alcoholism is a progressive disease. – Alcoholics must give themselves to a higher power. – Total abstinence • Effectiveness ?
  • 28. Public Health Premature Safety in Brain Interpersonal Traffic cirrhosis Heart Cost Deaths overdose Damage Violence Accidents Damage to society (UK) (Billion Per year Pounds) 10,000 +/year ethanol 22,000 1500 10 x Yes ++ ++ 18.5 Pleasure dose ecstasy 0.01 10 15 x ? 0 0 0 0 Nutt, D.J. (2006) J. Psychopharmacology, 20, 315-317.
  • 29. Summary • Pharmacokinetics: enzymes • Pharmacodynamics: neurotransmitters • Teratology: consequences – Randall: http://videocast.nih.gov/launch.asp?10420 • Epidemiology: Who uses? What are risk factors? Total Length = 57.4 minutes